BSEAstonea Labs Ltd· Pharmaceuticals & BiotechnologyHighPositive
Announced Fri, 6 Feb, 2026 · 15:41 IST

Outcome of Board Meeting dated 06.02.2026

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.1%Reaction day
₹157.00
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+2.6%-2.7% vs market
Pharmaceuticals peers, median of 159sector+1.8%-1.9% vs sector

On the reaction day the stock moved 2.7 pts less than Nifty Microcap 250 and 1.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.1+2.6-2.7+1.8-1.9
Next day
-3.5+3.6-7.1+2.4-5.9
2d
+1.9+3.1-1.2+2.0-0.1
3d
-1.2+2.6-3.8+1.3-2.5
4d
+1.9+1.1+0.8+0.7+1.2
5d
+0.0+0.3-0.3+0.0+0.0
1w
-1.3+1.6-2.9+0.8-2.0
15d
+1.0-3.9+4.9-4.4+5.3
1m
—-8.1—-5.2—
2m
+1.9-3.1+5.0-3.0+4.9
3m
+8.3+9.2-0.9+4.6+3.7
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board of Astonea Labs, at its meeting on 6 February 2026, approved the purchase of land at Village Haripur, Tehsil Raipur Rani, Panchkula, Haryana, for expanding its existing manufacturing/plant/factory facility. The specific consideration amount has not been disclosed in the filing. Director Pardeep Dalal (DIN: 02424111) has been authorised to sign, execute, and register the sale/conveyance deed and all related documents. The meeting ran from 2:30 p.m. to 3:15 p.m.

Likely market impact

This is a capacity-expansion move, generally a positive signal for future growth, but the absence of a disclosed deal value means investors cannot immediately gauge the financial impact or debt implications. Shareholders should watch for further disclosures on the deal size and funding plan.